文献速递艾滋病与性传播感染

接受抑制性抗逆转录病毒治疗期间较高的抗巨细胞病毒免疫球蛋白G浓度与较差的神经认知表现相关

Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.
PubMed 文献 · Clin Infect Dis · 2018-01-01

该横断面分析检测了80名HIV感染成人储存标本中的血抗CMV IgG、血和脑脊液CMV DNA及脑脊液7种可溶性生物标志物,其中38人接受抑制性ART、42人未接受ART。抗CMV IgG水平与更差神经认知表现总体呈边缘关联(P=0.059),该关联仅见于接受抑制性ART者(P=0.0049),多变量模型校正后仍相关(模型P=0.0038)。作者认为CMV可能影响接受抑制性ART的HIV感染成人的神经认知表现,未来抗CMV治疗临床试验有助于判断因果关系。

要点

  • 抗CMV IgG浓度范围为5.2至46.1 IU/mL,7份(8.8%)血浆标本检出CMV DNA,脑脊液标本均未检出。
  • 较高抗CMV IgG水平与较差神经认知表现的关联仅见于接受抑制性ART者(P=0.0049)。
  • 多变量模型校正其他协变量后,较差神经认知表现仍与较高抗CMV IgG水平相关(模型P=0.0038)。

核心结论

  • CMV可能影响接受抑制性ART的HIV感染成人的神经认知表现。
  • 未来抗CMV治疗的临床试验应有助于判断所观察到的关系是否为因果关系。

研究设计与样本

  • 横断面分析,检测80名HIV感染成人储存标本中的血抗CMV IgG、血和脑脊液CMV DNA及脑脊液7种可溶性生物标志物。
  • 80人中38人接受抑制性ART,42人未接受ART。

主要发现

  • 抗CMV IgG浓度范围为5.2至46.1 IU/mL。
  • 7份(8.8%)血浆标本检出CMV DNA,脑脊液标本均未检出。
  • 较高抗CMV IgG水平与较大年龄(P=0.0017)、较低CD4+ T细胞最低值(P<0.001)、AIDS(P<0.001)及较高可溶性CD163(P=0.009)相关。
  • 较高抗CMV IgG水平与较差神经认知表现总体呈边缘关联(P=0.059),该关联仅见于接受抑制性ART者(P=0.0049)。
  • 多变量模型校正其他协变量后,较差神经认知表现仍与较高抗CMV IgG水平相关(模型P=0.0038);可检出血浆CMV DNA与AIDS相关(P=0.05),但与神经认知表现无关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cytomegalovirus (CMV) has been linked to higher risk of cardiovascular disease and mortality. We aimed to determine if CMV is associated with neurocognitive performance in adults infected with human immunodeficiency virus (HIV). METHODS: In this cross-sectional analysis, anti-CMV immunoglobulin G (IgG) concentrations in blood and CMV DNA copies in blood and cerebrospinal fluid (CSF) were measured in stored specimens of 80 HIV-infected adults who were previously assessed with a comprehensive neurocognitive test battery. Thirty-eight were taking suppressive antiretroviral therapy (ART) and 42 were not taking ART. A panel of 7 soluble biomarkers was measured by immunoassay in CSF. RESULTS: Anti-CMV IgG concentrations ranged from 5.2 to 46.1 IU/mL. CMV DNA was detected in 7 (8.8%) plasma specimens but in no CSF specimens. Higher anti-CMV IgG levels were associated with older age (P = .0017), lower nadir CD4+ T-cell count (P < .001), AIDS (P < .001), and higher soluble CD163 (P = .009). Higher anti-CMV IgG levels trended toward an association with worse neurocognitive performance overall (P = .059). This correlation was only present in those taking suppressive ART (P = .0049). Worse neurocognitive performance remained associated with higher anti-CMV IgG levels after accounting for other covariates in multivariate models (model P = .0038). Detectable plasma CMV DNA was associated with AIDS (P = .05) but not with neurocognitive performance. CONCLUSIONS: CMV may influence neurocognitive performance in HIV-infected adults taking suppressive ART. Future clinical trials of anti-CMV therapy should help to determine whether the observed relationships are causal.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Letendre S, Bharti A, Perez-Valero I, et al. Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy. Clin Infect Dis. 2018. PMID: 29506084. doi:10.1093/cid/ciy170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。